These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 17051614)
1. Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes. Thevis M; Wilkens F; Geyer H; Schänzer W Rapid Commun Mass Spectrom; 2006; 20(22):3393-402. PubMed ID: 17051614 [TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864 [TBL] [Abstract][Full Text] [Related]
3. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. Bredehöft M; Schänzer W; Thevis M Rapid Commun Mass Spectrom; 2008; 22(4):477-85. PubMed ID: 18236437 [TBL] [Abstract][Full Text] [Related]
4. Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry--a matter for doping control analysis. Thevis M; Geyer H; Schänzer W Rapid Commun Mass Spectrom; 2005; 19(7):928-36. PubMed ID: 15747323 [TBL] [Abstract][Full Text] [Related]
5. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control. Virus ED; Sobolevsky TG; Rodchenkov GM J Mass Spectrom; 2008 Jul; 43(7):949-57. PubMed ID: 18563856 [TBL] [Abstract][Full Text] [Related]
6. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry. Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123 [TBL] [Abstract][Full Text] [Related]
7. Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis. Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT Rapid Commun Mass Spectrom; 2007; 21(18):3015-23. PubMed ID: 17708509 [TBL] [Abstract][Full Text] [Related]
8. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry. Kolmonen M; Leinonen A; Pelander A; Ojanperä I Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652 [TBL] [Abstract][Full Text] [Related]
9. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry. Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426 [TBL] [Abstract][Full Text] [Related]
10. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry. Thevis M; Guddat S; Schänzer W Steroids; 2009 Mar; 74(3):315-21. PubMed ID: 19007801 [TBL] [Abstract][Full Text] [Related]
11. Direct injection liquid chromatography/electrospray ionization mass spectrometric horse urine analysis for the quantification and confirmation of threshold substances for doping control. II. Determination of theobromine. Vonaparti A; Lyris E; Panderi I; Koupparis M; Georgakopoulos C Rapid Commun Mass Spectrom; 2009 Apr; 23(7):1020-8. PubMed ID: 19263423 [TBL] [Abstract][Full Text] [Related]
12. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification. Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923 [TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls. Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079 [TBL] [Abstract][Full Text] [Related]
14. Validation and application of a screening method for beta2-agonists, anti-estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometry. Kang MJ; Hwang YH; Lee W; Kim DH Rapid Commun Mass Spectrom; 2007; 21(2):252-64. PubMed ID: 17171780 [TBL] [Abstract][Full Text] [Related]
15. Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry: comparison between liquid-liquid extraction and direct injection. Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT J Chromatogr A; 2009 Jul; 1216(31):5819-27. PubMed ID: 19560151 [TBL] [Abstract][Full Text] [Related]
16. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry. Vonaparti A; Lyris E; Angelis YS; Panderi I; Koupparis M; Tsantili-Kakoulidou A; Peters RJ; Nielen MW; Georgakopoulos C Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1595-609. PubMed ID: 20486255 [TBL] [Abstract][Full Text] [Related]
17. Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing. Kuuranne T; Thomas A; Leinonen A; Delahaut P; Bosseloir A; Schänzer W; Thevis M Rapid Commun Mass Spectrom; 2008; 22(3):355-62. PubMed ID: 18181226 [TBL] [Abstract][Full Text] [Related]
18. Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison. Hintikka L; Kuuranne T; Leinonen A; Thevis M; Schänzer W; Halket J; Cowan D; Grosse J; Hemmersbach P; Nielen MW; Kostiainen R J Mass Spectrom; 2008 Jul; 43(7):965-73. PubMed ID: 18563858 [TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric determination of insulins and their degradation products in sports drug testing. Thevis M; Thomas A; Schänzer W Mass Spectrom Rev; 2008; 27(1):35-50. PubMed ID: 18000882 [TBL] [Abstract][Full Text] [Related]
20. Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry. Thomas A; Kohler M; Schänzer W; Kamber M; Delahaut P; Thevis M Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2669-74. PubMed ID: 19630025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]